Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165–241. https://doi.org/10.1093/eurheartj/ehy340.

Article  PubMed  Google Scholar 

Lip GY, Beevers M, Churchill D, Shaffer LM, Beevers DG. Effect of atenolol on birth weight. Am J Cardiol. 1997;79(10):1436–8. https://doi.org/10.1016/s0002-9149(97)00163-x.

Article  CAS  PubMed  Google Scholar 

Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. BMJ. 1990;301(6752):587–9. https://doi.org/10.1136/bmj.301.6752.587.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gaudineau A. Prevalence, risk factors, maternal and fetal morbidity and mortality of intrauterine growth restriction and small-for-gestational age. J Gynecol Obstet Biol Reprod (Paris). 2013;42(8):895–910. https://doi.org/10.1016/j.jgyn.2013.09.013.

Article  CAS  PubMed  Google Scholar 

Morris RK, Johnstone E, Lees C, Morton V, Smith G, Royal College of Obstetricians and Gynaecologists. Investigation and care of a small-for-gestational-age fetus and a growth restricted fetus (Green-top guideline No. 31). BJOG Int J Obstet Gynaecol. 2024;131(9):e31–80. https://doi.org/10.1111/1471-0528.17814.

Article  Google Scholar 

Kayser A, Beck E, Hoeltzenbein M, et al. Neonatal effects of intrauterine metoprolol/bisoprolol exposure during the second and third trimester: a cohort study with two comparison groups. J Hypertens. 2020;38(2):354–61. https://doi.org/10.1097/HJH.0000000000002256.

Article  CAS  PubMed  Google Scholar 

Hoeltzenbein M, Fietz AK, Kayser A, Zinke S, Meister R, Weber-Schoendorfer C, et al. Pregnancy outcome after first trimester exposure to bisoprolol: an observational cohort study. J Hypertens. 2018;36(10):2109–17. https://doi.org/10.1097/HJH.0000000000001818.

Article  CAS  PubMed  Google Scholar 

Ersbøll AS, Hedegaard M, Søndergaard L, Ersbøll M, Johansen M. Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction. BJOG Int J Obstet Gynaecol. 2014;121(5):618–26. https://doi.org/10.1111/1471-0528.12522.

Article  PubMed  Google Scholar 

Tanaka K, Tanaka H, Kamiya C, et al. Beta-blockers and fetal growth restriction in pregnant women with cardiovascular disease. Circ J. 2016;80(10):2221–6. https://doi.org/10.1253/circj.CJ-15-0617.

Article  CAS  PubMed  Google Scholar 

Kubota K, Inai K, Shimada E, Shinohara T. α/β- and β-blocker exposure in pregnancy and the risk of neonatal hypoglycemia and small for gestational age. Circ J. 2023;87(4):569–77. https://doi.org/10.1253/circj.CJ-22-0647.

Article  CAS  PubMed  Google Scholar 

Meidahl Petersen K, Jimenez-Solem E, Andersen JT, et al. β-blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study. BMJ Open. 2012;2(4):e001185. https://doi.org/10.1136/bmjopen-2012-001185.

Article  PubMed  PubMed Central  Google Scholar 

Halpern DG, Weinberg CR, Pinnelas R, Mehta-Lee S, Economy KE, Valente AM. Use of medication for cardiovascular disease during pregnancy: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(4):457–76. https://doi.org/10.1016/j.jacc.2018.10.075.

Article  PubMed  Google Scholar 

Gelson E, Curry R, Gatzoulis MA, Swan L, Lupton M, Steer P, et al. Effect of maternal heart disease on fetal growth. Obstet Gynecol. 2011;117(4):886–91. https://doi.org/10.1097/AOG.0b013e31820cab69.

Article  PubMed  Google Scholar 

Cauldwell M, Steer P, Sterrenburg M, Wallace S, Malin G, Ulivi G, et al. Birth weight in pregnancies complicated by maternal heart disease. Heart. 2019;105(5):391–8. https://doi.org/10.1136/heartjnl-2018-313551.

Article  PubMed  Google Scholar 

Thorne S, MacGregor A, Nelson-Piercy C. Risks of contraception and pregnancy in heart disease. Heart. 2006;92:1520–5.

Article  PubMed  PubMed Central  Google Scholar 

COLLÈGE NATIONAL DES GYNÉCOLOGUES ET OBSTÉTRICIENS FRANÇAIS, Winer N, Caroit Y, Sbelin JE, Hilippe HJP. Mises à jour en Gynécologie et Obstétrique Publié le 10 décembre 2010. J Gynecol Obstet Biol Reprod. 2010;39:S1–342.

Google Scholar 

Dabi Y, Thubert T, Fuchs F, Barjat T, Belaisch-Allart J, Ceccaldi PF, et al. How is functioning the Ethical Review Board « Comité d’Ethique pour la Recherche en Obstétrique et Gynécologie » (CEROG)? J Gynecol Obstet Hum Reprod. 2022;51:102352. https://doi.org/10.1016/j.jogoh.2022.102352.

Article  PubMed  Google Scholar 

Grewal J, Siu SC, Lee T, D’Souza R, Dvir M, Singer J, et al. Impact of beta-blockers on birth weight in a high-risk cohort of pregnant women with CVD. J Am Coll Cardiol. 2020;75(21):2751–2. https://doi.org/10.1016/j.jacc.2020.03.068.

Article  PubMed  Google Scholar 

Duan L, Ng A, Chen W, Spencer HT, Lee MS. Beta-blocker subtypes and risk of low birth weight in newborns. J Clin Hypertens (Greenwich). 2018;20(11):1603–9. https://doi.org/10.1111/jch.13397.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sørbye IK, Haualand R, Wiull H, Letting AS, Langesaeter E, Estensen ME. Maternal beta-blocker dose and risk of small-for gestational-age in women with heart disease. Acta Obstet Gynecol Scand. 2022;101(7):794–802. https://doi.org/10.1111/aogs.14363.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hardee I, Wright L, McCracken C, Lawson E, Oster ME. Maternal and neonatal outcomes of pregnancies in women with congenital heart disease: a meta-analysis. J Am Heart Assoc. 2021;10(8):e017834. https://doi.org/10.1161/JAHA.120.017834.

Article  PubMed  PubMed Central  Google Scholar 

Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol. 2007;49(24):2303–11. https://doi.org/10.1016/j.jacc.2007.03.027.

Article  PubMed  Google Scholar 

Cuneo BF, Kaizer AM, Clur SA, et al. Mothers with long QT syndrome are at increased risk for fetal death: findings from a multicenter international study. Am J Obstet Gynecol. 2020;222(3):263.e1-263.e11. https://doi.org/10.1016/j.ajog.2019.09.004.

Article  PubMed  Google Scholar 

Centre de référence Syndrome de Marfan et apparentés. Protocole National de Diagnostic et de Soins (PNDS) Syndrome de Marfan et apparentés. HAS; 2018. https://www.has-sante.fr/upload/docs/application/pdf/2018-03/pnds_syndrome_de_marfan_et_apparente_mars_2018_def.pdf.

Centre de Référence des Maladies cardiaques héréditaires, Hôpital Bichat APHP, Dr Isabelle DENJOY, Centre de référence pour la prise en charge des maladies rythmiques héréditaires de, l’Ouest, CHU Nantes, Dr Isabelle DENJOY; Pr Vincent PROBST. Protocole National de Diagnostic et de Soins (PNDS) Syndrome du QT Long. HAS; 2021. https://www.has-sante.fr/upload/docs/application/pdf/2021-10/1._protocole_national_de_diagnostic_et_de_soins_syndrome_du_qt_long_cardiogen_isabelle_denjoy.pdf.

Centre de référence des Malformations Cardiaques Congénitales Complexes. Protocole National de Diagnostic et de Soins (PNDS) PRISE EN CHARGE DE LA GROSSESSE CHEZ LES PATIENTES AVEC UNE CARDIOPATHIE CONGENITALE COMPLEXE. HAS. Août 2021. https://www.has-sante.fr/upload/docs/application/pdf/2021-11/pnds_ccc_et_grossesse2021texte.pdf.

Bateman BT, Patorno E, Desai RJ, et al. Late pregnancy β blocker exposure and risks of neonatal hypoglycemia and bradycardia. Pediatrics. 2016;138(3):e20160731. https://doi.org/10.1542/peds.2016-0731.

Article  PubMed  PubMed Central  Google Scholar 

Lind J, Wallenburg HC. The Marfan syndrome and pregnancy: a retrospective study in a Dutch population. Eur J Obstet Gynecol Reprod Biol. 2001;98(1):28–35. https://doi.org/10.1016/s0301-2115(01)00314-1.

Article  CAS  PubMed  Google Scholar 

Lunel A, Audra P, Plauchu H, Gaucherand P. Syndrome de Marfan et grossesse. J Gynecol Obstet Biol Reprod (Paris). 2006;35(6):607–13. https://doi.org/10.1016/s0368-2315(06)76450-x.

Article  CAS  PubMed  Google Scholar 

Rossiter JP, Repke JT, Morales AJ, Murphy EA, Pyeritz RE. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol. 1995;173(5):1599–606. https://doi.org/10.1016/0002-9378(95)90655-x.

Article  CAS  PubMed  Google Scholar 

Ishibashi K, Aiba T, Kamiya C, Miyazaki A, Sakaguchi H, Wada M, et al. Arrhythmia risk and β-blocker therapy in pregnant women with long QT syndrome. Heart. 2017;103(17):1374–9. https://doi.org/10.1136/heartjnl-2016-310617.

Article